>
The New Wheat EVERY Home Baker Needs to Know About!
Popular Amazon.com DC Fuse Showdown: Continuous Load Heat Test,...
What I Learned at This Week's White House Press Conference
Unraveling the Mystery of Who Assassinated Charlie Kirk and Why
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
Millions Of America's Teens Are Being Seduced By AI Chatbots
Transhumanist Scientists Create Embryos From Skin Cells And Sperm

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.